nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0933	0.187	CbGeAlD
Rocuronium—CHRNA1—tongue—amyotrophic lateral sclerosis	0.0788	0.158	CbGeAlD
Rocuronium—HTR3A—nerve—amyotrophic lateral sclerosis	0.0478	0.0958	CbGeAlD
Rocuronium—HTR3A—brainstem—amyotrophic lateral sclerosis	0.0205	0.0411	CbGeAlD
Rocuronium—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.0186	0.0374	CbGeAlD
Rocuronium—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.017	0.134	CcSEcCtD
Rocuronium—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.0166	0.0333	CbGeAlD
Rocuronium—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.015	0.0302	CbGeAlD
Rocuronium—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0147	0.115	CcSEcCtD
Rocuronium—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.0145	0.029	CbGeAlD
Rocuronium—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0145	0.113	CcSEcCtD
Rocuronium—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.0142	0.0284	CbGeAlD
Rocuronium—CHRNA1—brain—amyotrophic lateral sclerosis	0.0139	0.0278	CbGeAlD
Rocuronium—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.0132	0.0264	CbGeAlD
Rocuronium—CHRNA2—brain—amyotrophic lateral sclerosis	0.0115	0.0231	CbGeAlD
Rocuronium—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.0113	0.0226	CbGeAlD
Rocuronium—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0849	CcSEcCtD
Rocuronium—HTR3A—nervous system—amyotrophic lateral sclerosis	0.0108	0.0216	CbGeAlD
Rocuronium—CHRNB1—brain—amyotrophic lateral sclerosis	0.0107	0.0215	CbGeAlD
Rocuronium—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.0104	0.0208	CbGeAlD
Rocuronium—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.0101	0.0202	CbGeAlD
Rocuronium—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.00946	0.0253	CbGpPWpGaD
Rocuronium—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00925	0.0725	CcSEcCtD
Rocuronium—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00907	0.071	CcSEcCtD
Rocuronium—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00897	0.018	CbGeAlD
Rocuronium—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00881	0.0177	CbGeAlD
Rocuronium—HTR3A—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00865	0.0232	CbGpPWpGaD
Rocuronium—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00864	0.0173	CbGeAlD
Rocuronium—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00849	0.017	CbGeAlD
Rocuronium—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00849	0.017	CbGeAlD
Rocuronium—HTR3A—brain—amyotrophic lateral sclerosis	0.00822	0.0165	CbGeAlD
Rocuronium—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00817	0.0164	CbGeAlD
Rocuronium—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00799	0.016	CbGeAlD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00764	0.0204	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00758	0.0203	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00705	0.0189	CbGpPWpGaD
Rocuronium—CHRM2—brain—amyotrophic lateral sclerosis	0.00686	0.0137	CbGeAlD
Rocuronium—SLC22A1—brain—amyotrophic lateral sclerosis	0.00674	0.0135	CbGeAlD
Rocuronium—SLC22A1—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00656	0.0176	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00649	0.0174	CbGpPWpGaD
Rocuronium—SLCO1A2—brain—amyotrophic lateral sclerosis	0.00649	0.013	CbGeAlD
Rocuronium—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00648	0.0508	CcSEcCtD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00623	0.0167	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00617	0.0165	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00599	0.016	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00574	0.0154	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00569	0.0152	CbGpPWpGaD
Rocuronium—SLC22A1—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00563	0.0151	CbGpPWpGaD
Rocuronium—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0427	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0053	0.0142	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00529	0.0142	CbGpPWpGaD
Rocuronium—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0404	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00512	0.0137	CbGpPWpGaD
Rocuronium—Shock—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0397	CcSEcCtD
Rocuronium—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.0394	CcSEcCtD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00503	0.0135	CbGpPWpGaD
Rocuronium—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00501	0.0134	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00488	0.0131	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00488	0.0131	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00488	0.0131	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00488	0.0131	CbGpPWpGaD
Rocuronium—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00482	0.0377	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00468	0.0125	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00464	0.0124	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0045	0.0121	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0044	0.0118	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00435	0.0116	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00435	0.0116	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00435	0.0116	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00428	0.0115	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00413	0.0111	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00406	0.0109	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00398	0.0107	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00392	0.0105	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00388	0.0104	CbGpPWpGaD
Rocuronium—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0298	CcSEcCtD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00378	0.0101	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00374	0.01	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0037	0.0099	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0037	0.0099	CbGpPWpGaD
Rocuronium—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0286	CcSEcCtD
Rocuronium—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00359	0.0096	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00355	0.00951	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00351	0.00941	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00351	0.00941	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00345	0.00924	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00333	0.00892	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00333	0.00892	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00333	0.00892	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0033	0.00883	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00328	0.00878	CbGpPWpGaD
Rocuronium—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0257	CcSEcCtD
Rocuronium—Rash—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0255	CcSEcCtD
Rocuronium—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0254	CcSEcCtD
Rocuronium—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00317	0.00848	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00313	0.00839	CbGpPWpGaD
Rocuronium—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00306	0.024	CcSEcCtD
Rocuronium—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00305	0.00816	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00301	0.00806	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00297	0.00795	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0029	0.00775	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00283	0.00759	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00283	0.00759	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0028	0.00748	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00269	0.00721	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00269	0.00721	CbGpPWpGaD
Rocuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00257	0.00687	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00253	0.00677	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00253	0.00676	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0024	0.00643	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00231	0.00617	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00213	0.0057	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00213	0.0057	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00211	0.00565	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00211	0.00564	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00197	0.00526	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00196	0.00525	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00194	0.00519	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0019	0.00508	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00184	0.00494	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.0018	0.00482	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.0018	0.00482	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.0018	0.00482	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00179	0.0048	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00174	0.00465	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00166	0.00445	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00165	0.00442	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00165	0.00442	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00163	0.00437	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00161	0.00432	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00161	0.00432	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.0016	0.00428	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00154	0.00412	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00151	0.00403	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00147	0.00394	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00145	0.00389	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00144	0.00385	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00133	0.00356	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00131	0.0035	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.0013	0.00348	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00126	0.00338	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00126	0.00338	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00124	0.00331	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00124	0.00331	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00121	0.00325	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00117	0.00312	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0011	0.00295	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00107	0.00287	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00107	0.00287	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00103	0.00276	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00103	0.00275	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00103	0.00275	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000958	0.00256	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000939	0.00251	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000932	0.0025	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000911	0.00244	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000911	0.00244	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000873	0.00234	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000821	0.0022	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000812	0.00217	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000786	0.0021	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000782	0.00209	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00075	0.00201	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00075	0.00201	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000743	0.00199	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000686	0.00184	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000665	0.00178	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000665	0.00178	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000638	0.00171	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0006	0.00161	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000593	0.00159	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000567	0.00152	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000563	0.00151	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000542	0.00145	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000519	0.00139	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000473	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000466	0.00125	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00045	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000444	0.00119	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000426	0.00114	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000411	0.0011	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000403	0.00108	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000395	0.00106	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000389	0.00104	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000379	0.00102	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000343	0.000918	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000314	0.000842	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000311	0.000834	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000296	0.000791	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00028	0.00075	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000271	0.000727	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000267	0.000714	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000241	0.000645	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000238	0.000638	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000229	0.000614	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000211	0.000564	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000199	0.000533	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000194	0.000519	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000176	0.000471	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000173	0.000464	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000167	0.000448	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000164	0.000438	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000154	0.000412	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000154	0.000411	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000146	0.000391	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000127	0.000339	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000125	0.000335	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000119	0.000318	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000118	0.000315	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000104	0.000278	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.68e-05	0.000259	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.67e-05	0.000232	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8e-05	0.000214	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.16e-05	0.000165	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.82e-05	0.000156	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.23e-05	0.00014	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.95e-05	0.000106	CbGpPWpGaD
